SGS North America Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 616 Heathrow Dr, Lincolnshire, Illinois (IL) 60069, United States (USA)
- Operations here
- analysis
- FDA identifiers
- FEI 1418028 · DUNS 049859261
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-03-20
- VAIDrug Quality Assurance2023-01-10
- NAIDrug Quality Assurance2019-04-24
- NAIDrug Quality Assurance2017-02-14
- NAIDrug Quality Assurance2014-11-21
- NAIDrug Quality Assurance2012-12-03
- NAIDrug Quality Assurance2010-11-30
- NAIDrug Quality Assurance2010-05-27
- NAIDrug Quality Assurance2009-08-14
Drugs this plant is listed as making
9 distinct drugs across 14 products name this site in their FDA label.
- amifampridine phosphateCatalyst Pharmaceuticals, Inc.
- aprepitantHeron Therapeutics, Inc.
- buprenorphine hydrochloride, naloxone hydrochlorideIndivior Inc.
- Desmopressin Acetate Oral SolutionEton Pharmaceuticals, Inc.
- HydrocortisoneEton Pharmaceuticals, Inc.
- MebrofeninBracco Diagnostics Inc
- RisperidoneIndivior Inc.
- Sodium ThiosulfateFennec Pharmaceuticals Inc.
- Zinc AcetateEton Pharmaceuticals, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.